Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targetable elements in SARS-CoV-2 S2 subunit for the design of pan-coronavirus fusion inhibitors and vaccines
Liyan Guo, Sheng Lin, Zimin Chen, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

Conserved role of spike S2 domain N-glycosylation across betacoronaviruses
Qi Yang, Anju Kelkar, Balaji Manicassamy, et al.
npj Viruses (2025) Vol. 3, Iss. 1
Open Access | Times Cited: 1
A comprehensive review on immunogen and immune-response proteins of SARS-CoV-2 and their applications in prevention, diagnosis, and treatment of COVID-19
Daohong Zhang, Deepak Kukkar, Ki‐Hyun Kim, et al.
International Journal of Biological Macromolecules (2024) Vol. 259, pp. 129284-129284
Closed Access | Times Cited: 6
Fluorescence‐Quenching Lateral Flow Immunoassay for “Turn‐On” and Sensitive Detection of Anti‐SARS‐Cov‐2 Neutralizing Antibodies in Human Serum
Lun Bian, Fu Qiangqiang, Zhuoheng Gan, et al.
Advanced Science (2023) Vol. 11, Iss. 4
Open Access | Times Cited: 14
Computational optimization of a pan-coronavirus fusion inhibitory peptide targeting Spike’s heptapeptide repeat region
Peixiang Gao, Shuo Liu, Xiaojing Chi, et al.
Biosafety and Health (2025)
Open Access
Diketopiperazine/piperidine alkaloid as a potential broad-spectrum coronaviral entry inhibitor identified by supercomputer-based virtual screening from a large natural product-based library
Nasim Shahhamzehei, Sara Abdelfatah, Ejlal A. Omer, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 183, pp. 117841-117841
Closed Access
Revisiting the potential of natural antimicrobial peptides against emerging respiratory viral disease: a review
Neelakanta Sarvashiva Kiran, Sudarshan Singh, Chandrashekar Yashaswini, et al.
3 Biotech (2025) Vol. 15, Iss. 2
Closed Access
Passive infusion of an S2-Stem broadly neutralizing antibody protects against SARS-CoV-2 infection and lower airway inflammation in rhesus macaques
Christopher T Edwards, Kirti A. Karunakaran, Elijah Garcia, et al.
PLoS Pathogens (2025) Vol. 21, Iss. 1, pp. e1012456-e1012456
Open Access
Recombinant protein HR212 targeting heptad repeat 2 domain in spike protein S2 subunit elicits broad‐spectrum neutralizing antibodies against SARS‐CoV‐2 and its variants
Ying Lu, An‐Qi Li, Fan Shen, et al.
MedComm (2025) Vol. 6, Iss. 2
Open Access
A shark-derived broadly neutralizing nanobody targeting a highly conserved epitope on the S2 domain of sarbecoviruses
Bo Feng, Cuiyun Li, Zhaoyong Zhang, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
Functional Activity and Binding Specificity of Small Ankyrin Repeat Proteins Called Ankyrons Against SARS-CoV-2 Variants
Yun-Jong Park, Wojciech Jankowski, Nicholas C. Hurst, et al.
The AAPS Journal (2025) Vol. 27, Iss. 2
Open Access
Molecular basis of two broad-spectrum antibodies neutralizing rabies virus and other phylogroup-I lyssaviruses by blocking structural transition between the pleckstrin-homology and fusion domains in the glycoprotein
Fanli Yang, Lili Zhai, Keqing Yin, et al.
International Journal of Biological Macromolecules (2025), pp. 142570-142570
Closed Access
Structural basis and mode of action for two broadly neutralizing nanobodies targeting the highly conserved spike stem-helix of sarbecoviruses including SARS-CoV-2 and its variants
Liyan Guo, Zimin Chen, Sheng Lin, et al.
PLoS Pathogens (2025) Vol. 21, Iss. 4, pp. e1013034-e1013034
Open Access
Positively Charged-Amylose-Entangled Au-Nanoparticles Acting as Protein Carriers and Potential Adjuvants to SARS-CoV-2 Subunit Vaccines
Baochao Fan, Jun Gu, Bin Deng, et al.
ACS Applied Materials & Interfaces (2023) Vol. 15, Iss. 25, pp. 29982-29997
Closed Access | Times Cited: 12
Current Status and Perspectives of Therapeutic Antibodies Targeting the Spike Protein S2 Subunit against SARS-CoV-2
Yuichiro Yamamoto, Tetsuya Inoue
Biological and Pharmaceutical Bulletin (2024) Vol. 47, Iss. 5, pp. 917-923
Open Access | Times Cited: 4
Exploring Conformational Landscapes and Cryptic Binding Pockets in Distinct Functional States of the SARS-CoV-2 Omicron BA.1 and BA.2 Trimers: Mutation-Induced Modulation of Protein Dynamics and Network-Guided Prediction of Variant-Specific Allosteric Binding Sites
Gennady M. Verkhivker, Mohammed Alshahrani, Grace Gupta
Viruses (2023) Vol. 15, Iss. 10, pp. 2009-2009
Open Access | Times Cited: 8
Comparative Analysis of Conformational Dynamics and Systematic Characterization of Cryptic Pockets in the SARS-CoV-2 Omicron BA.2, BA.2.75 and XBB.1 Spike Complexes with the ACE2 Host Receptor: Confluence of Binding and Structural Plasticity in Mediating Networks of Conserved Allosteric Sites
Mohammed Alshahrani, Grace Gupta, Sian Xiao, et al.
Viruses (2023) Vol. 15, Iss. 10, pp. 2073-2073
Open Access | Times Cited: 8
A Mini-Review on the Common Antiviral Drug Targets of Coronavirus
Jun Wang, Qinghe Zhu, Xiaoxu Xing, et al.
Microorganisms (2024) Vol. 12, Iss. 3, pp. 600-600
Open Access | Times Cited: 2
The Effect of Select SARS-CoV-2 N-Linked Glycan and Variant of Concern Spike Protein Mutations on C-Type Lectin-Receptor-Mediated Infection
Arjan Bains, Wenyan Guan, Patricia J. LiWang
Viruses (2023) Vol. 15, Iss. 9, pp. 1901-1901
Open Access | Times Cited: 5
Development of a bispecific nanobody conjugate broadly neutralizes diverse SARS-CoV-2 variants and structural basis for its broad neutralization
Jing Yang, Sheng Lin, Zimin Chen, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 11, pp. e1011804-e1011804
Open Access | Times Cited: 5
Novel S2 subunit-specific antibody with broad neutralizing activity against SARS-CoV-2 variants of concern
Chang-Kyu Heo, Won-Hee Lim, Jihyun Yang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
Research Progress on Spike-Dependent SARS CoV-2 Fusion Inhibitors and Small Molecules Targeting the S2 Subunit of Spike
Matthew R. Freidel, Roger S. Armen
(2024)
Open Access | Times Cited: 1
The Dual-Targeted Fusion Inhibitor Clofazimine Binds to the S2 Segment of the SARS-CoV-2 Spike Protein
Matthew R. Freidel, Pratiti A. Vakhariya, Shalinder K. Sardarni, et al.
(2024)
Open Access | Times Cited: 1
Research Progress on Spike-Dependent SARS-CoV-2 Fusion Inhibitors and Small Molecules Targeting the S2 Subunit of Spike
Matthew R. Freidel, Roger S. Armen
Viruses (2024) Vol. 16, Iss. 5, pp. 712-712
Open Access | Times Cited: 1
Discovery of anti-SARS-CoV-2 S2 protein antibody CV804 with broad-spectrum reactivity with various beta coronaviruses and analysis of its pharmacological properties in vitro and in vivo
Yoji Tsugawa, Kentaro Furukawa, Tomoko Ise, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Humoral immunity across the SARS-CoV-2 Spike after Sputnik V (Gam‑COVID‑Vac) vaccination
Alejandro Cornejo, Christopher Franco, Mariajosé Rodríguez, et al.
(2024)
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top